27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) made its public debut on Thursday morning, opening at $14.50 after being priced at $16 per share.
Fulcrum focuses on developing therapies for genetically defined diseases in areas of high unmet needs, with a specific focus on rare diseases. The company uses its product engine to identify targets that can be drugged by small molecules, regardless of the particular underlying mechanism of gene misexpression.
Morgan Stanley, Bank of America Merrill Lynch and SVB Leerink are the underwriters for the offering.
The stock traded around $14.36 per share at time of publication.
Related Links:
Fulcrum Therapeutics IPO: What You Need To Know
Owl Rock Capital Opens Above IPO Price
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!